Pentagon opens military supply chain to biobased products—if they can prove it
H.R. 5191 — To direct the Under Secretary of Defense for Research and Engineering to issue guidance for private entities on demonstrating how biobased products meet Department of Defense requirements, and for other purposes. · Filed by Ro Khanna (D-CA) · 2 cosponsors · Introduced Sep 8, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Pentagon's research chief to create guidance helping private companies prove their biobased products (made from living organisms or biological processes) meet military standards. It also orders the Government Accountability Office to audit whether Pentagon procurement rules accidentally exclude biobased products and recommend fixes. The bill aims to open military supply chains to biological alternatives without changing actual defense requirements.
Why we flagged it
The bill's operative mechanism is removing informational and analytical barriers to a new product category in military procurement. It does not mandate biobased purchases, change specifications, or create subsidies—it clarifies how companies can compete and audits whether existing rules inadvertently exclude them.
What the text implies
- If DoD requirements processes are found to exclude biobased products, the Comptroller General's recommendations may trigger policy changes affecting existing suppliers and contracts.
- Guidance issued under this bill could become de facto standard for evaluating biobased products across federal procurement, extending impact beyond DoD.
- The bill does not mandate adoption of biobased products—it only removes barriers; actual market uptake depends on cost, performance, and DoD purchasing decisions.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Citizens benefit from expanded competition in military supply chains, potentially lower costs through alternative materials, and environmental gains if biobased products reduce fossil-fuel dependence. The bill creates no new mandates or restrictions on citizens—it only removes barriers to market entry for a new product category and increases transparency about procurement bias.
Who stands to gain
- biobased product manufacturers and biotech companies
- agricultural and biotechnology sectors seeking military contracts
Named in the bill
Under Secretary of Defense for Research and Engineering, Secretaries of the military departments, Comptroller General of the United States, Congressional defense committees, Department of Defense, biobased product manufacturers
Where it stands
2 cosponsors: 2 Democrats.
- Sep 8, 2025 — Introduced · Congress.gov: “Introduced in House”
- Sep 8, 2025 — Referred to House Committee on Armed Services · Congress.gov: “Referred to the House Committee on Armed Services”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,438 characters) on Jun 3, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Pentagon opens military supply chain to biobased products—if they can prove it” QuorumCivic. https://share.quorumcivic.app/bill/119/hr5191 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.